Kezar Life Sciences, Inc. (KZR)
7.36
-0.02
(-0.27%)
USD |
NASDAQ |
May 07, 10:28
Kezar Life Sciences Free Cash Flow : -51.78M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Apellis Pharmaceuticals, Inc. | 45.01M |
| ACADIA Pharmaceuticals, Inc. | 6.308M |
| Alnylam Pharmaceuticals, Inc. | 641.34M |
| Savara, Inc. | -101.06M |
| BioMarin Pharmaceutical, Inc. | 759.12M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -11.96M |
| Cash from Investing (Quarterly) | 51.61M |
| Cash from Financing (Quarterly) | -6.707M |
| Free Cash Flow Per Share (Quarterly) | -1.633 |
| Free Cash Flow to Equity (Quarterly) | -4.376M |
| Free Cash Flow to Firm (Quarterly) | -11.96M |
| Free Cash Flow Yield | -96.16% |